Tenaya therapeutics to participate in upcoming investor conferences

South san francisco, calif., feb. 07, 2023 (globe newswire) -- tenaya therapeutics, inc. (nasdaq: tnya), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that company management will participate in the svb securities global biopharma conference and cowen's 43rd annual health care conference. details of participation are as follows:
TNYA Ratings Summary
TNYA Quant Ranking